Proto Labs (PRLB) EBT Margin (2011 - 2026)

Proto Labs has disclosed EBT Margin across 16 years of filings, most recently posting 8.12% for Q1 2026.

• EBT Margin for Q1 2026 came in at 8.12%, up 338.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.66% (up 207.0% YoY), and the FY2025 annual result was 5.83%, up 90.0% from the prior year.
• EBT Margin came in at 8.12% for Q1 2026 at Proto Labs, up from 5.97% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 8.21% in Q3 2023 to a low of 100.95% in Q4 2022.
• The 5-year median for EBT Margin is 5.86% (2024), against an average of 0.76%.
• Across the five-year window, EBT Margin slumped 11141 bps in 2022 and surged 10890 bps in 2023, its largest moves.
• Proto Labs' EBT Margin stood at 100.95% in 2022, then soared by 108 bps to 7.95% in 2023, then plunged by 103 bps to 0.23% in 2024, then surged by 2679 bps to 5.97% in 2025, then surged by 36 bps to 8.12% in 2026.
• The last three EBT Margin figures came in at 8.12% (Q1 2026), 5.97% (Q4 2025), and 7.57% (Q3 2025), per Business Quant data.